Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain

European Journal of Physical and Rehabilitation Medicine

Volumn 49, Issue 5, 2013, Pages 659-664

  Battisti, E ^a   Albanese, A ^a   Guerra, L ^b   Argnani, L ^c   Giordano, N ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Alfa Wassermann SpA   (Italy)

^c Hematology Institute L e a Semgnoli   (Italy)

Author keywords

Chronic pain; Low back pain; Neuralgia.; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; SCAVENGER; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

AGED; ARTICLE; CHRONIC PAIN; DRUG COMBINATION; FEMALE; HUMAN; ITALY; LOW BACK PAIN; MALE; METHODOLOGY; NEURALGIA; OXIDATIVE STRESS; PAIN ASSESSMENT; PHYSIOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTIOXIDANTS; CHRONIC PAIN; DRUG THERAPY, COMBINATION; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; ITALY; LOW BACK PAIN; MALE; NEURALGIA; OXIDATIVE STRESS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 84891763377     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bratton RL. Assessment and management of acute low back pain. Am Fam Physician 1999;60:2299-308.
2. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F et al. COST B13 working group on guidelines for chronic low back pain. european guidelines for the management of non specific low back pain. Eur Spine J 2006;15:S192-300.
3. Andersson GBJ. Epidemiological features of chronic low back pain. Lancet 1999;354:581-5. (Pubitemid 29381383)
4. Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medication use for low back pain in primary care. Spine 1998;23:607-14. (Pubitemid 28154975)
5. Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-91. (Pubitemid 351688341)
6. Goertz M, Thorson D, Bonseil J, Bonte B, Campbell R, Haake B et al. Institute for Clinical Systems Improvement. Adult Acute and Subacute Low Back Pain, [cited 2013 June 4]. Available at: http://bit.ly.LBPl 112
7. Italian Society of Orthopaedics and Traumatology (SIOT) Guidelines. Mal di schiena. banca dati comparativa tra linee guida e analisi critica delle raccomandazioni. GIOT 2011;37:113-30.
8. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997;13:116-37. (Pubitemid 27251106)
9. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: A literature review. Arch Intern Med 2003;163:2433-45. (Pubitemid 37385786)
10. Bosley BN, Weiner DK, Rudy TE, Granieri E. Is chronic nonmalignant pain associated with decreased appetite in older adults? Preliminary evidence. J Am Geriatr Soc 2004;52:247-51. Benca RM, Ancoli-Israel S, Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry 2004;65:26-35.
11. Cooper JK, Kohlmann T. Factors associated with health status of older Americans. Age Ageing 2001;30:495-501. (Pubitemid 34071490)
12. Thomas CH, MacAdams D. Back pain rehabilitation. Aust Fam Physician 2004;33:427-30.
13. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997;70:3-14. (Pubitemid 27128292)
14. Ceriello A, Testa R. Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 2009;32(Suppl 2):S232-6.
15. Vincent AM, Edwards JL, Sadidi M, Feldman EL. Thea antioxidant response as a drug target in diabetic neuropathy. Current Drug Targets 2008;9:94-100.
16. Berger JV, Knaepen L, Janssen SP, Jaken RJ, Marcus MA, Joosten EA, Deumens R. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approach. Brain Res Rev 2011;67:282-310.
17. Vallejio R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010;10:167-84.
18. Rosales-Corral S, Reiter RJ, Tan DX, Ortiz GG, Lopez-Armas G. Functional aspects of redox control during neuroinflammation. Antioxid Redox Signal 2010;13:193-247.
19. Kim HY, Chung JM, Chung K. Increased production of mitochondrial superoxide in the spinal cord induces pain behavlours in mice: the effect of mithocondrial electron transport complex inhibitors. Neurosci Lett 2008;447:87-91.
20. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: A critical review. Treat Endocrinol 2004;3:17389.
21. Abdin AA, Sarhan NI. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenoneinduced parkinsonism and L-dopa toxicity. Neurosci Res 2011;71:387-95.
22. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy. Diabetes Care 2006;29:2365-70. (Pubitemid 44912237)
23. Ziegler D. Painful diabetic neuropathy: Advantage of novel drugs over old drugs? Diabetes Care 2009;32:S414-9.
24. Mijnhout GS, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid: A new treatment for neuropathic pain in patients with diabetes? The Netherlands Journal of Medicine 2010;68:158-62.
25. Ranieri M, Sciuscio M, Musci L. Efficacia e sicurezza della supplementazione con acido alfa-lipoico ALA e acido gammalinolenico GLA nel trattamento della rachialgia: studio osservazionale preliminare. Eur Med Phys 2008;2008;44:1 4.
26. Ranieri M, Sciuscio M, Cortese AM, Santamato A, Di Teo L, Ianieri G et al. The use of alpha-lipoic acid (ALA), gamma linolenic acid GLA and rehabilitation in the treatment of back pain: effeet on health-related quality of life. Int J Immunopathol Pharmacol 2009;22(3 Suppl):45-50.
27. Memeo A, Loiero M. Thioctic acid and acetyl-L-Carnitine in the treatment of sciatic pain caused by herniated disc. Clin Drug Invest 2008;28:495-500.
28. Levin ED. Extracellular superoxide dismutase (EC-SOD) quenches free radicals and attenuates age-related cognitive decline: opportunities for novel drug development in aging. Curr Alzheimer Res 2005;2:191-6. (Pubitemid 40862881)
29. Viggiano E, Monda M, Viggiano A, Viggiano A, Aurilio C, De Luca B. Persistent facial pain increases superoxide anion production in the spinal trigeminal nucleus. Mol Cell Biochem 2010;339:149-54.
30. Nakajima S, Ohsawa I, Nagata K, Ohta S, Olmo M, Ijichi T et al. Oral supplementation with melon superoxide dismutase extract promotes antioxidant defences in the brain and prevents stress-induced impairment of spatial memory. Behavioural Brain Research 2009;200:15-21.
31. Bertolotto F, Massone A. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs R D 2012;12:29-34.
32. Lee FH, Raja SN. Complementary and alternative medicine in chronic pain. Pain 2011;152:28-30.
33. Packer L, Tritscher HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radie Biol Med 1997;22:359-78.
34. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-70. (Pubitemid 44912237)
35. Milesi MA, Lacan D, Brosse H, Desor D, Notin C. Effect of an oral supplementation with a proprietary melon juice concentrate (Extramel) on stress and fatigue in healthy people: A pilot, double-blind, placebo-controlled clinical trial. Nutr J 2009;8:40.
36. Depalma MJ, Ketchum JM, Saullo TR. Multivariable analyses of the relationships between age, gender, and body mass index and the source of chronic low back pain. Pain Med 2012 [Epub ahead of print].